The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Scenario 1:
Use docking to predicted how Erlotinib (an approved drug) binds to the Epidermal Growth Factor Receptor
2HYY, the receptor and ligand generated from be_blasti.py.
